Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection

British Journal of Cancer

Volumn 107, Issue 12, 2012, Pages 2010-2015

  Chu, C M ^a   Lin, C C ^a   Chen, Y C ^a   Jeng, W J ^a   Lin, S M ^a   Liaw, Y F ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

basal core promoter mutant; Cirrhosis; HBV DNA levels; HBV genotypes; hepatocellular carcinoma; precore mutant

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; BASAL CORE PROMOTER; CANCER PATIENT; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HETEROZYGOTE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; VIRUS MUTANT; VIRUS MUTATION; VIRUS PATHOGENESIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; PROMOTER REGIONS, GENETIC;

EID: 84870825165     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.474     Document Type: Article

References (33)

1. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma.Hepatology 42: 1208-1236
2. Chan HL (2011) Significance of hepatitis B virus genotypes and mutationsin the development of hepatocellular carcinoma in Asia. J GastroenterolHepatol 26: 8-12
3. Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW, Sung JJ (2004)Genotype C hepatitis B virus infection is associated with an increasedrisk of hepatocellular carcinoma. Gut 53: 1494-1498
4. Chen CH, Lee CM, Lu SN, Changchien CS, Eng HL, Huang CM, Wang JH,Hung CH, Hu TH (2005) Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV eantigen expression in Taiwan. J Clin Microbiol 43: 6000-6005
5. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH,REVEAL-HBV Study Group (2006) Risk of hepatocellular carcinomaacross a biological gradient of serum hepatitis B virus DNA level. JAMA295: 65-73
6. Chu CM, Liaw YF (2005) Genotype C hepatitis B virus infection isassociated with a higher risk of reactivation of hepatitis B andprogression to cirrhosis than genotype B: a longitudinal study ofhepatitis B e antigen-ositive patients with normal aminotransferaselevels at baseline. J Hepatol 43: 411-417
7. Chu CM, Chen YC, Tai DI, Liaw YF (2010) Level of Hepatitis B virus DNAin inactive carriers with persistently normal levels of alanine aminotransferase.Clin Gastroenterl Hepatol 8: 535-540
8. Chu CM, Yeh CT, Chiu CT, Sheen IS, Liaw YF (1996) Precore mutant ofhepatitis B virus prevails in acute and chronic infections in an area inwhich hepatitis B is endemic. J Clin Microbiol 134: 1815-1818
9. Fang ZL, Sabin CA, Dong BQ, Ge LY, Wei SC, Chen QY, Fang KX, Yang JY,Wang XY, Harrison TJ (2008) HBV A1762T, G1764A mutations are avaluable biomarker for identifying a subset of male HBsAg carriers atextremely high risk of hepatocellular carcinoma: A prospective study.Am J Gastroenterol 103: 2254-2262
10. Fang ZL, Yang J, Ge X, Zhuang H, Gong J, Li R, Ling R, Harrison TJ (2002)Core promoter mutations (A(1762)T and G(1764)A) and viral genotypein chronic hepatitis B and hepatocellular carcinoma in Guangxi, China.J Med Virol 68: 33-40
11. Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, RealdiG, Ruol A (1991) Natural history and prognostic factors for chronichepatitis type B. Gut 32: 294-298
12. Fattovich G, Stroffolini T, Zagni I, Nonato F (2004) Hepatocellular carcinomain cirrhosis: incidence and risk factors. Gastroenterology 127: S35-S50
13. Fujie H, Moriya K, Shintani Y, Yotsuyanagi H, Iino S, Koike K (2001)Hepatitis B virus genotypes and hepatocellular carcinoma in Japan.Gastroenterology 120: 1564-1565
14. Iavarone M, Trabut JB, Delpuech O, Carnot F, Colombo M, Kremsdorf D,Bréchot C, Thiers V (2003) Characterization of hepatitis B virus Xprotein mutants in tumor and non-tumor liver cells using laser capturemicrodissection. J Hepatol 39: 253-261
15. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ, Risk evaluation of viralload elevation and associated liver disease/cancer-in HBV (the REVEALHBV)Study Group (2006) Predicting cirrhosis risk based on the level ofcirculating hepatitis B viral load. Gastroenterology 130: 678-686
16. Kao JH (2002) Hepatitis B viral genotypes: clinical relevance and molecularcharacteristics. J Gastroenterol Hepatol 17: 643-650
17. Kao JH, Chen PJ, Lai MY, Chen DS (2000) Hepatitis B genotypescorrelate with clinical outcomes in patients with chronic hepatitis B.Gastroenterology 118: 554-559
18. Kao JH, Chen PJ, Lai MY, Chen DS (2003) Basal core promoter mutations ofhepatitis B virus increase the risk of hepatocellular carcinoma inhepatitis B carriers. Gastroenterology 124: 327-334
19. Liaw YF, Chu CM (2009) Hepatitis B virus infection. Lancet 373: 582-592
20. Liaw YF, Tai DI, Chu CM, Chen TJ (1988) The development of cirrhosis inpatients with chronic type B hepatitis: a prospective study. Hepatology 8:493-496
21. Lin CL, Liao LY, Wang CS, Chen PJ, Lai MY, Chen DS, Kao JH (2005) Basalcore promoter mutant of hepatitis B virus and progression of liverdisease in hepatitis B e antigen-negative chronic hepatitis B. Liver Int 25:564-570
22. Lin DY, Sheen IS, Chiu CT, Lin SM, Kuo YC, Liaw YF (1993)Ultrasonographic changes of early liver cirrhosis in chronic hepatitisB: a longitudinal study. J Clin Ultrasound 21: 303-308
23. Lindh M, Hannoun C, Dhillon AP, Norkans G, Horal P (1999) Corepromoter mutations and genotypes in relation to viral replicationand liver damage in East Asian hepatitis B virus carriers. J Infect Dis 179:775-782
24. Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, Chen DS (2006)Role of hepatitis B viral load and basal core promoter mutation inhepatocellular carcinoma in hepatitis B carriers. J Infect Dis 193:1258-1265
25. Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G (2009) Associations betweenhepatitis B virus mutations and the risk of hepatocellular carcinoma: ameta-analysis. J Natl Cancer Inst 101: 1066-1082
26. Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T,Okanoue T, Yotsuyanagi H, Iino S (2001) A case-control study forclinical and molecular biological differences between hepatitis B virusesof genotypes B and C. Japan HBV Genotype Research Group. Hepatology33: 218-223
27. Sugauchi F, Orito E, Ichida T, Kato H, Sakugawa H, Kakumu S, Ishida T,Chutaputti A, Lai CL, Gish RG, Ueda R, Miyakawa Y, Mizokami M (2003)Frequent coinfection with hepatitis B virus strains of distinct genotypesdetected by hybridization with type-specific probes immobilized on asolid-hase support. J Virol Methods 110: 29-35
28. Tai DI, Lin SM, Sheen IS, Chu CM, Lin DY, Liaw YF (2009) Long-termoutcome of hepatitis B e antigen-negative hepatitis B surface antigencarriers in relation to changes of alanine aminotransferase levels overtime. Hepatology 49: 1859-1867
29. Takahashi K, Aoyama K, Ohno N, Iwata K, Akahane Y, Baba K, YoshizawaH, Mishiro S (1995) The precore/core promoter mutant (T1762A1764) ofhepatitis B virus: clinical significance and an easy method for detection.J Gen Virol 76: 3159-3164
30. Tong MJ, Blatt LM, Kao JH, Cheng JT, Corey WG (2007) Basal corepromoter T 1762/A1764 and precore A1896 gene mutations in hepatitis Bsurface antigen-ositive hepatocellular carcinoma: a comparison withchronic carriers. Liver Int 27: 1356-1363
31. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, Wang LY, Lu SN, YouSL, Chen DS, Liaw YF, Chen CJ, REVEAL-HBV Study Group (2008)Associations between hepatitis B virus genotype and mutantsand the risk of hepatocellular carcinoma. J Natl Cancer Inst 100:1134-1143
32. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, ChenDS, Chen CJ (2005) Hepatitis B virus genotype and DNA level andhepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst97: 265-272
33. Yuen MF, Tanaka Y, Shinkai N, Poon RT, But DY, Fong DY, Fung J, WongDK, Yuen JC, Mizokami M, Lai CL (2008) Risk for hepatocellularcarcinoma with respect to hepatitis B virus genotypes B/C, specificmutations of enhancer II/core promoter/precore regions and HBV DNAlevels. Gut 57: 98-102